New Drug Shows Promise
A new drug has shown remarkable results in extending the lifespans of mice by nearly 25%, leaving scientists hopeful that it could have the same effect on humans. Dubbed as “supermodel grannies” in the lab, the treated mice appeared young and healthy compared to their untreated counterparts.
Anti-Ageing Effects
The drug not only extended the healthy lives of the mice but also led to fewer instances of cancer in the treated group. By targeting a protein called interleukin 11 (IL-11) that increases with age in humans, the drug was able to control the pace of ageing and improve overall health.
Promising Results in Mice
The mice treated with the drug lived an average of 155 weeks compared to 120 weeks for the untreated mice. They showed improved muscle function, leaner bodies, healthier fur, and scored better on measures of frailty, indicating a significant improvement in health and vitality.
Human Trials Underway
While the drug is already being tested on humans for other conditions, its potential anti-ageing effects are yet to be fully understood. Researchers remain optimistic about the possibilities and are hopeful that the drug could lead to healthier ageing in humans as well.
Potential Impact on Aging Population
Although the effects of IL-11 inhibition in humans are still being studied, the initial results in mice are promising. The research opens up new possibilities for extending healthy ageing and reducing frailty in the elderly population.
Did you miss our previous article...
https://trendinginthenews.com/cancer/youths-diet-dominated-by-junk-food-study-reveals
